Recent advances in the study of uveitis.
D000328:Adult; D000906:Antibodies / Q000032:analysis; D000937:Antigen-Antibody Reactions; D001082:Aqueous Humor; D001379:Azathioprine / Q000627:therapeutic use; D002464:Cell Migration Inhibition; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006649:Histocompatibility Antigens / Q000032:analysis; D006801:Humans; D007111:Immunity, Cellular; D007429:Intraocular Pressure; D037102:Lectins / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects; D008727:Methotrexate / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000150:complications; D011453:Prostaglandins / Q000378:metabolism; D013167:Spondylitis, Ankylosing / Q000150:complications; D013587:Syphilis / Q000150:complications; D014605:Uveitis / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D014777:Virus Diseases / Q000150:complications
D000906:Antibodies; D006649:Histocompatibility Antigens; D037102:Lectins; D011453:Prostaglandins; D002699:Chlorambucil; D003520:Cyclophosphamide; D001379:Azathioprine; D008727:Methotrexate